Clinical trial
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot…
NCT00296036 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00296036 |
|---|---|
| Title | Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer |
| Official title | A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug, Other |
| Interventions | pyridoxine hydrochloride, urea/lactic acid-based topical cream, placebo |
| Enrollment | 137 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2009 |
| First posted | Feb 24, 2006 |
| Last update posted | Mar 16, 2017 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: